Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Suppr

超能文献

作者信息

Crawford D H, Thomas J A, Janossy G, Sweny P, Fernando O N, Moorhead J F, Thompson J H

出版信息

Lancet. 1980 Jun 21;1(8182):1355-6. doi: 10.1016/s0140-6736(80)91800-0.

DOI:10.1016/s0140-6736(80)91800-0

PMID:6104142

Abstract

摘要

相似文献

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Lancet. 1980 Jun 21;1(8182):1355-6. doi: 10.1016/s0140-6736(80)91800-0.

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma.环孢素A免疫抑制、爱泼斯坦-巴尔抗体与淋巴瘤

Lancet. 1980 Mar 8;1(8167):536-7. doi: 10.1016/s0140-6736(80)92784-1.

Cyclosporin A, transplantation, and lymphoma.

Lancet. 1980 Dec 13;2(8207):1296. doi: 10.1016/s0140-6736(80)92354-5.

Cyclosporin A and the media.环孢素A与培养基。

Br Med J. 1980 Jan 5;280(6206):43. doi: 10.1136/bmj.280.6206.43.

Malignant lymphoma in cyclosporin A treated allograft recipients.接受环孢素A治疗的同种异体移植受者中的恶性淋巴瘤。

Lancet. 1980 Jan 5;1(8158):43. doi: 10.1016/s0140-6736(80)90579-6.

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A.接受环孢素A治疗的肾移植受者对EB病毒的长期T细胞介导免疫。

Lancet. 1981 Jan 3;1(8210):10-2. doi: 10.1016/s0140-6736(81)90115-x.

Epstein-Barr viral infection in renal allograft recipients: a single center experience.肾移植受者的爱泼斯坦-巴尔病毒感染：单中心经验

Saudi J Kidney Dis Transpl. 2006 Sep;17(3):351-4.

Two cases of benign lumps after treatment with cyclosporin A.两例使用环孢素A治疗后出现的良性肿块。

Lancet. 1980 Oct 11;2(8198):795. doi: 10.1016/s0140-6736(80)90401-8.

Cyclosporin A immunosuppression and Epstein-Barr antibody.环孢素A免疫抑制与爱泼斯坦-巴尔抗体

Lancet. 1981 Jul 25;2(8239):196-7. doi: 10.1016/s0140-6736(81)90372-x.

Immunity to Epstein-Barr virus in cyclosporin A-treated renal allograft recipients.环孢素 A 治疗的肾移植受者对爱泼斯坦 - 巴尔病毒的免疫

Lancet. 1982 Jun 26;1(8287):1469-70. doi: 10.1016/s0140-6736(82)92479-5.

引用本文的文献

Adoptive T-cell therapy targeting Epstein-Barr virus as a treatment for multiple sclerosis.靶向爱泼斯坦-巴尔病毒的过继性T细胞疗法作为多发性硬化症的一种治疗方法。

Clin Transl Immunology. 2023 Mar 21;12(3):e1444. doi: 10.1002/cti2.1444. eCollection 2023.

The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.爱泼斯坦-巴尔病毒免疫逃逸蛋白BCRF1和BPLF1通过一种独立于经典晚期起始前复合物的机制表达。

PLoS Pathog. 2016 Nov 17;12(11):e1006008. doi: 10.1371/journal.ppat.1006008. eCollection 2016 Nov.

Epstein-Barr virus: more than 50 years old and still providing surprises.EB 病毒：50 多岁，仍不断带来惊喜。

Nat Rev Cancer. 2016 Dec;16(12):789-802. doi: 10.1038/nrc.2016.92. Epub 2016 Sep 30.

The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.顺式作用重复序列家族既能抑制也能刺激oriP复制子的建立。

J Virol. 2001 Nov;75(22):10709-20. doi: 10.1128/JVI.75.22.10709-10720.2001.

Biology and disease associations of Epstein-Barr virus.爱泼斯坦-巴尔病毒的生物学特性及与疾病的关联

Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):461-73. doi: 10.1098/rstb.2000.0783.

The Epstein-Barr virus and its association with human cancers.爱泼斯坦-巴尔病毒及其与人类癌症的关联。

Mol Pathol. 1999 Dec;52(6):307-22. doi: 10.1136/mp.52.6.307.

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.实体器官移植患者发生移植后淋巴细胞增生性疾病时，爱泼斯坦-巴尔病毒特异性细胞毒性T细胞的激活与过继转移

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10391-6. doi: 10.1073/pnas.96.18.10391.

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.供体与受体类型的爱泼斯坦-巴尔病毒在移植后淋巴细胞增生性疾病中的作用。

Springer Semin Immunopathol. 1998;20(3-4):375-87. doi: 10.1007/BF00838050.

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).移植后淋巴细胞增生性疾病（PTLD）的临床和病理特征。

Springer Semin Immunopathol. 1998;20(3-4):325-42. doi: 10.1007/BF00838047.

The mother lode of liver transplantation, with particular reference to our new journal.肝移植的丰富资源，特别是关于我们的新期刊。

Liver Transpl Surg. 1998 Jan;4(1):1-14. doi: 10.1002/lt.500040101.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验